Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
B4GALT1, encoded by the B4GALT1 gene located at human chromosome 9p21.1, is a type II membrane-bound glycosyltransferase of the Golgi apparatus. It has an N-terminal transmembrane anchor and a catalytic domain in the Golgi lumen. The protein has a molecular weight of approximately 44 kDa. Rather than acting as a soluble enzyme, B4GALT1 transfers galactose in a beta-1,4 linkage from UDP-galactose to acceptor sugars. It contributes to glycoconjugate and N-linked oligosaccharide biosynthesis, and in lactating mammary tissue it forms lactose synthase with alpha-lactalbumin.
B4GALT1 is a galactosyltransferase that participates in glycosylation. Its catalytic activity adds galactose to glycan structures, and its unique role in both glycoconjugate and lactose biosynthesis distinguishes it among the beta-1,4-galactosyltransferase family. The Golgi localization and glycosyltransferase activity of B4GALT1 make it a useful target for research on glycan biosynthesis, glycosylation, and carbohydrate metabolism.
Fig. 1 A schematic diagram illustrating the proposed mechanism by which B4GALT1 regulates HCC invasiveness.1
B4GALT1, encoded by the B4GALT1 gene, functions as a Golgi galactosyltransferase that catalyzes glycan biosynthesis:
Creative Biolabs offers high-quality B4GALT1 proteins produced using optimized expression systems, including full-length enzyme and isolated catalytic domain variants. As a galactosyltransferase, B4GALT1 is suitable for studies of glycan biosynthesis, enzyme activity, and glycosylation. These proteins can support investigation of glycoconjugate synthesis and lactose production. All B4GALT1 proteins undergo strict quality control to support consistent performance across applicable research platforms.
Not finding the protein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides custom-engineered B4GALT1 stable cell lines, including overexpression and blank control models. These cell lines are optimized for studies of glycosylation and glycan biosynthesis. Each cell line undergoes stringent validation to ensure stable expression profiles and consistent functional performance in diverse experimental contexts.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
High-specificity recombinant antibodies targeting B4GALT1 are developed using antibody engineering technologies for research applications involving B4GALT1 expression and localization. These antibodies can be used in studies of B4GALT1 distribution in the Golgi apparatus and may also support characterization of glycosylation in combination with appropriate detection reagents.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for B4GALT1 research:
B4GALT1 is a Golgi galactosyltransferase that transfers galactose to acceptor sugars, contributing to glycan and lactose biosynthesis.
B4GALT1 catalyzes key steps in glycosylation, and studying it informs the molecular mechanisms of glycan biosynthesis and carbohydrate metabolism.
No, all B4GALT1 products and services are strictly for research use only, not intended for clinical diagnosis or treatment.
Offerings include full-length B4GALT1 proteins, custom B4GALT1 stable cell lines, and B4GALT1-specific recombinant antibodies for glycan research.
B4GALT1 products are suitable for studies of galactose transfer, glycosylation, glycan biosynthesis, and lactose synthesis.